Clik here to view.
Trueman男性医院、女性化乳房手術を25,700件以上施行し、韓国の女性化乳房症手術の優秀性を立証
韓国ソウル （ビジネスワイヤ） — Trueman男性医院は、2010年から2022年9月現在までに25,700件以上の女性化乳房症手術を施行したと発表した。Trueman男性医院は、韓国で有名な男性疾患専門病院として9軒のクリニックを運営している。...
View ArticleClik here to view.
Trueman 男性医院实施女乳症手术25,700例以上，证明了韩国女乳症手术的优秀性
韩国首尔 (美国商业资讯)– Trueman男性医院日前发布消息称，自2010年至2022年9月，共实施了超过26,000例女乳症手术。Trueman 男性医院是韩国著名的男性疾病专科医院，共开设有9家诊所。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20221006005462/zh-CN/ Trueman...
View ArticleClik here to view.
Trueman Man Clinic Network Demonstrates Its Excellence in Gynecomastia...
SEOUL, South Korea Trueman Man Clinic Network announced that it has performed more than 25,700 gynecomastia operations as of September 2022 from 2010. Trueman Man Clinic Network is a renowned...
View ArticleClik here to view.
CANbridge Pharmaceuticals to Participate in Upcoming Investor Conferences
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals, Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development and commercialization...
View ArticleClik here to view.
Medtech Startup NousQ Receives US$175K Grand Prize for Pediatric Ear Tube...
LOS ANGELES & SINGAPORE MedTech Innovator, the largest accelerator of medical devices in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only...
View ArticleClik here to view.
Genuv Unveils GNUV205, a Bifunctional Fusion Protein That Potently Regresses...
SEOUL, Republic of Korea & CAMBRIDGE, Mass. Genuv Inc., a clinical-stage biotechnology company focused on innovative drug discovery for degenerative central nervous system diseases and advanced...
View ArticleClik here to view.
Veristat Joins Decentralized Trials ＆ Research Alliance (DTRA) to Improve the...
SOUTHBOROUGH, Mass. Veristat announced that it has joined an alliance of over 120 life sciences and healthcare organizations whose mission is to accelerate the broad adoption of patient-focused,...
View ArticleClik here to view.
Prestige Biopharma Submitted Pre-BLA Type 4 Meeting Request to FDA for...
SINGAPORE Prestige Biopharma Limited, a Singapore-based biopharmaceutical company, has submitted a request to the U.S. Food and Drug Administration (FDA) for a pre-submission meeting to discuss the...
View ArticleClik here to view.
Wyss Center for Bio and Neuroengineering：神经记录系统新瞭望
日内瓦 (美国商业资讯)–Wyss Center for Bio and Neuroengineering新发布的一份白皮书揭示了ABILITY脑机接口(BCI)系统记录的首批神经信号。此外，白皮书还阐述了即将进行的ABILITY人体临床试验计划，目的是使因脑干中风或肌萎缩性脊髓侧索硬化症(ALS)而处于锁定状态的患者具备沟通能力。Wyss...
View ArticleClik here to view.
Wyss Center for Bio and Neuroengineeringが神経記録システムの新たな地平を示す
ジュネーブ （ビジネスワイヤ） — Wyss Center for Bio and...
View ArticleClik here to view.
Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the...
View ArticleClik here to view.
Clik here to view.
Qihan Biotech Appoints Tony W. Ho to its Board of Directors
HANGZHOU, China Hangzhou Qihan Biotech Co., Ltd. (“Qihan” or “Qihan Biotech” or “the Company”), an industry leader in applying multiplexable genome editing technology to cell therapies and organ...
View ArticleClik here to view.
武田薬品、EUおよびデング熱流行国におけるデング熱ワクチン候補の承認推奨に関するCHMPの肯定的見解を受領
大阪 & 米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） —...
View ArticleClik here to view.
Biocytogen to Present Progress of Preclinical and Clinical Assets at...
BEIJING Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) will present at the upcoming BIO-EUROPE conference in Leipzig, Germany on October 24-26 and virtually on November...
View ArticleClik here to view.
Teijin Automotive Technologies’ Teams Get Creative for a Cause
AUBURN HILLS, Mich. When the Operations and Health and Safety management teams of Teijin Automotive Technologies gathered in San Antonio, Texas, earlier this month, operational improvement was not...
View ArticleClik here to view.
Clik here to view.
Syncromune, Inc. Enters into an Exclusive Worldwide License Agreement with...
FORT LAUDERDALE, Fla. & BEIJING Syncromune, Inc., a clinical stage biopharmaceutical company focused on the development of combination intratumoral immunotherapy announced today that the Company...
View ArticleClik here to view.
Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, Licenses OX40...
BEIJING & FORT LAUDERDALE, Fla. Eucure (Beijing) Biopharma Co., Ltd. (“Eucure”), a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”), announced today that...
View ArticleClik here to view.
Impellaのロープロファイル・シースが米国FDAより510(k)の認可を取得
米マサチューセッツ州・ダンバース アビオメッド（Nasdaq: ABMD）が開発したImpella のロープロファイル・シースが、米国食品医薬品局（FDA）より510(k)承認を取得しましたのでお知らせします。このシースは、Impella CPの留置に使用されている従来の14Fr（フレンチ）のシースと比較して、内径はそのままに、外径が約2Fr小さくなりました。...
View Article